文章來源：上海國資(zi)委 發布(bu)時間：2013-05-10
近日，上(shang)海創(chuang)投(tou)(tou)公(gong)司會同(tong)全球第二醫藥(yao)(yao)(yao)巨頭(tou)默沙(sha)(sha)(sha)東(dong)(dong)(dong)公(gong)司、楊(yang)浦(pu)科(ke)創(chuang)集團，與千(qian)(qian)驥(ji)(ji)諾格醫藥(yao)(yao)(yao)股權投(tou)(tou)資(zi)基金(jin)管理企(qi)業(ye)舉行(xing)了千(qian)(qian)驥(ji)(ji)創(chuang)新(xin)生(sheng)物(wu)醫藥(yao)(yao)(yao)基金(jin)簽(qian)約儀(yi)式。千(qian)(qian)驥(ji)(ji)創(chuang)新(xin)生(sheng)物(wu)醫藥(yao)(yao)(yao)基金(jin)由(you)上(shang)海創(chuang)投(tou)(tou)公(gong)司、默沙(sha)(sha)(sha)東(dong)(dong)(dong)(中國(guo))有(you)限公(gong)司、楊(yang)浦(pu)科(ke)創(chuang)集團共同(tong)出資(zi)設立(li)，規(gui)模3億元(yuan)，是國(guo)內首個(ge)專注(zhu)生(sheng)命科(ke)學早期創(chuang)新(xin)的(de)生(sheng)物(wu)醫藥(yao)(yao)(yao)基金(jin)，也(ye)是默沙(sha)(sha)(sha)東(dong)(dong)(dong)在北美歐(ou)洲外的(de)第一個(ge)合作(zuo)創(chuang)新(xin)基金(jin)。默沙(sha)(sha)(sha)東(dong)(dong)(dong)公(gong)司是國(guo)際第二大(da)醫藥(yao)(yao)(yao)巨頭(tou)，致力研發銷售創(chuang)新(xin)醫藥(yao)(yao)(yao)產品(pin)，擁(yong)有(you)全球制藥(yao)(yao)(yao)行(xing)業(ye)最富效率的(de)研發實力。